Dr. Jennifer L. Miller, MD

Dr. Miller practices at Ann & Robert H. Lurie Children's Hospital of Chicago in Chicago, Illinois, part of Ann & Robert H. Lurie Children's Hospital of Chicago.

Dr. Miller's NPI, 1508809989, was assigned on June 14, 2006. Dr. Miller graduated from University Of Florida College Of Medicine in 1998. Dr. Miller holds Florida license ME83410.

Dr. Miller's primary practice is Ann & Robert H. Lurie Children's Hospital of Chicago, at 225 E Chicago Ave, Box 140, Chicago, IL 60611 in Cook County. The practice phone is (312) 227-4000.

Dr. Miller's primary practice is Ann & Robert H. Lurie Children's Hospital of Chicago in Chicago, Illinois, part of Ann & Robert H. Lurie Children's Hospital of Chicago. Dr. Miller is also affiliated with UF Health Shands Hospital. The medical group on file is UF Health Physicians. Dmand AI also links Dr. Miller to 1 more clinical lab, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Miller practices, 3 sites in all. Vendor and product names are available with a free account.

Pediatric endocrinology is Dr. Miller's primary specialty in the NPI Registry, under taxonomy code 2080P0205X. Dr. Miller is board certified in pediatric endocrinology by the American Board of Pediatrics. Dmand AI has Dr. Miller's licenses on file in 4 states: Florida, North Carolina, Oklahoma and Alabama.

Dmand AI lists intellectual and developmental disabilities among the conditions Dr. Miller treats.

CMS data shows 25 Medicare services from Dr. Miller across 1 procedure code in 2024, all of them office visits, for 22 Medicare patients. Medicare paid $1,406 for them. Every service was in an office.

CMS counts 22 Medicare patients who saw Dr. Miller in 2024. The largest group is under 65, with 22 patients. 50% of them have mood disorders. 100% are also on Medicaid. Their average risk score is 0.69, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Miller's median patient age at 12, with 50% women.

In 2024, Dr. Miller wrote 749 Medicare Part D claims for 48 patients. 64% of them were for generic drugs. CMS names the drug for 640 of them, across 17 drugs with 11 or more claims each, at $449,290 in total drug cost. In 2023, CMS named 535 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Miller for performance year 2024, reported through an alternative payment model (APM). Dr. Miller accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 98 papers to Dr. Miller, published from 2005 to 2025. 2018 was the busiest year, with 7. The most frequent topics are Prader-Willi Syndrome, Hyperphagia and Obesity. Dr. Miller has published most often in Am J Med Genet A. Dr. Miller's most frequent co-authors are Daniel J. Driscoll, MD, PhD, Merlin G. Butler, MD, PhD and Virginia E. Kimonis, MD.

Dmand AI links Dr. Miller to 4 clinical trials. Conditions studied include Prader-Willi Syndrome and Imprinting Disorders. University of Florida sponsors the most, 2.

CMS Open Payments shows 30 general payments to Dr. Miller from 9 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 46% of the total. Soleno Therapeutics, Inc. paid the most, $46,101.

Dr. Miller graduated from University Of Florida College Of Medicine in 1998.

Dr. Miller is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.